News Detail
Washington, 23 Nov 2020: Researchers have shown that the effector functions of antibodies targeting SARS-CoV-2 are more important for protecting against COVID-19 (the disease caused by the virus) than their ability to prevent SARS-CoV-2 from infecting cells. The team also observe......
View Details
Source : Drug Target Review
Related News
- Dentist goes into septic shock days after vaccine in AP (28-01-2021)
- FSSAI asks state authorities to form helpdesk for smoother licensing & regn (28-01-2021)
- GSK transfers malaria vaccine production to Bharat Biotech (28-01-2021)
- Mumbai: Eight doctors reject Serum Institute’s Covishield, opt for Covaxin (28-01-2021)
- Regulate health e-service aggregators, states told (28-01-2021)
- SII seeks govt nod to ‘unblind’ trial data as volunteers ask if they got vaccine or placebo (28-01-2021)
- Bharat Biotech’s Covaxin neutralises UK strain of coronavirus: Study (28-01-2021)
- WHO issues new clinical advice on treating Covid-19 patients (27-01-2021)
- EU warns drug cos of strict export rules amid vax delays (27-01-2021)
- Hundreds of undigested pills found in patient's stomach in Kolkata (27-01-2021)